AdvanDx
OpGen to Acquire MDx Firm AdvanDx; Inks $6M Financing With Merck GHI
The acquisition will provide OpGen with FDA-approved and CE-marked tests for use with its MDRO Gene tests and bioinformatics for multidrug-resistant organisms.
AdvanDx Receives FDA Clearance for MRSA Assay
The test MRSA and MSSA directly from blood culture samples in about one hour, compared to between 48 and 72 hours with other methods, the company said.
MDx Firm AdvanDx Pulls in $12M
NEW YORK (GenomeWeb News) – AdvanDx, a provider of molecular diagnostics for pathogen identification, said today that it has closed a $12 million Series B-1 financing round.
AdvanDx Files for 510(k) Clearance of MRSA Assay
NEW YORK (GenomeWeb News) – Molecular diagnostics firm AdvanDx today announced it submitted a 510(k) application to the US Food and Drug Administration for clearance of its mecA XpressFISH test for the rapid detection of methicillin-resistant Staphylococcus aureus from S.
AdvanDx said this week that Heiner Dreismann has joined the company's board of directors as an independent director.
Mar 31, 2010
FDA Clears AdvanDx Fungal Test Speed-up
Dec 10, 2009
AdvanDx Gets FDA OK for Faster Staphylococcus Dx
Oct 27, 2009